SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer
Titel:
SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer
Auteur:
Munemoto, Y. Nakamura, M. Takahashi, M. Kotaka, M. Kuroda, H. Kato, T. Minagawa, N. Noura, S. Fukunaga, M. Kuramochi, H. Touyama, T. Takahashi, T. Miwa, K. Satake, H. Kurosawa, S. Miura, T. Mishima, H. Sakamoto, J. Oba, K. Nagata, N.